PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: Paradigm to Present at Evercore ISI HealthCONx Conference, page-204

  1. 113 Posts.
    lightbulb Created with Sketch. 19
    I think Scotty must have received some very angry calls from his Investors today, his 'concern' would be for the ongoing viability and integrity of his investment firm, considering how overweight he is in PAR. His reputation would be on the line here!
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.